117 participants
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2018-09-07
- Start Date:
- 2013-07-11
- Completion:
- 2013-08-05
Conditions
- Influenza
Interventions
- BIOLOGICAL